Yeah TLX592 seems OK in that respect though.
Early days but from their proof of concept study recently released;
Initial results demonstrate rapid elimination from blood circulation compared to standard antibodies and hepatic (liver) clearance – both highly desirable characteristics for use with alpha emitting agents.
- Forums
- ASX - By Stock
- CU6 - Media and Industry News
Yeah TLX592 seems OK in that respect though.Early days but from...
-
-
- There are more pages in this discussion • 230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.28 |
Change
0.055(0.88%) |
Mkt cap ! $1.981B |
Open | High | Low | Value | Volume |
$6.29 | $6.30 | $6.25 | $1.344M | 213.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 2232 | $6.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.28 | 1791 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 3231 | 6.270 |
11 | 3757 | 6.260 |
4 | 2651 | 6.250 |
4 | 1887 | 6.240 |
4 | 8407 | 6.230 |
Price($) | Vol. | No. |
---|---|---|
6.280 | 1582 | 4 |
6.290 | 3721 | 5 |
6.300 | 4393 | 8 |
6.310 | 729 | 3 |
6.320 | 23467 | 2 |
Last trade - 11.40am 15/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online